Relative replication fitness of efavirenz-resistant mutants of HIV-1: Correlation with frequency during clinical therapy and evidence of compensation for the reduced fitness of K103N + L100I by the nucleoside resistance mutation L74V

Documenti analoghi

• L74V increases the reverse transcriptase content of HIV-1 virions with non-nucleoside reverse transcriptase drug-resistant mutations L100I+K103N and K101E+G190S, which results in increased fitness
  di: Wang, Jiong, et al.
  Pubblicazione: (2013)
• The Non-nucleoside Reverse Transcriptase Inhibitor Efavirenz Stimulates Replication of Human Immunodeficiency Virus Type 1 Harboring Certain Non-nucleoside Resistance Mutations
  di: Wang, J., et al.
  Pubblicazione: (2010)
• Clinical Significance of Human Immunodeficiency Virus Type 1 Replication Fitness
  di: Dykes, Carrie, et al.
  Pubblicazione: (2007)
• Reduced Fitness in Cell Culture of HIV-1 with Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Mutations Correlates with Relative Levels of Reverse Transcriptase Content and RNase H Activity in Virions
  di: Wang, Jiong, et al.
  Pubblicazione: (2010)
• Nonnucleoside Reverse Transcriptase Inhibitor-Resistant HIV Is Stimulated by Efavirenz during Early Stages of Infection
  di: Wang, Jiong, et al.
  Pubblicazione: (2011)